PTC Therapeutics Inc (PTCT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Stuart W. Peltz
Employees:
517
100 CORPORATE COURT, SOUTH PLAINFIELD, NJ 07080-2449
9082227000

PTC Therapeutics, Inc. engages in the discovery, development, and commercialization of orally administered, small molecule therapeutics targeting an area of RNA biology. Its preclinical and discovery programs are focused on the development of new treatments for multiple therapeutic areas, including neuromuscular disease, oncology and infectious disease. It product, candidate ataluren, is used for the treatment of patients with genetic disorders that arise from a type of genetic mutation known as a nonsense mutation. The company was founded by Allan S. Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Data derived from most recent annual or quarterly report
Market Cap 2.258 Billion Shares Outstanding71.362 Million Avg 30-day Volume 620.916 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.89
Price to Revenue5.2111 Debt to Equity300.0236 EBITDA-361.037 Million
Price to Book Value1951.7917 Operating Margin-69.52239999999999 Enterprise Value2.465 Billion
Current Ratio1.874 EPS Growth-0.119 Quick Ratio1.735
1 Yr BETA 1.0419 52-week High/Low 45.8 / 30.03 Profit Margin-97.2722
Operating Cash Flow Growth-29.5052 Altman Z-Score-0.8286 Free Cash Flow to Firm -234.129 Million
Earnings Report2022-07-28
View SEC Filings from PTCT instead.

View recent insider trading info

Funds Holding PTCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PTCT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

12 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

2.3 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PAUWELS ERIC CHIEF BUSINESS OFFICER

49,772 2022-04-19 5

KLEIN MATTHEW B. CHIEF OPERATING OFFICER

56,564 2022-04-19 2

PELTZ STUART WALTER CHIEF EXECUTIVE OFFICER

38,646 2022-04-14 6

BOULDING MARK ELLIOTT EXEC. VP AND CLO

420,210 2022-04-13 7

HILL EMILY LUISA CHIEF FINANCIAL OFFICER

29,259 2022-03-31 5

ALMSTEAD NEIL GREGORY CHIEF TECHNICAL OPS OFFICER

  • Officer
51,273 2022-02-01 4

UTTER CHRISTINE MARIE SVP, FINANCE & CAO

  • Officer
25,405 2022-02-01 3

SOUTHWELL DAVID P

  • Director
18,500 2022-01-07 1

STEELE GLENN JR MD PHD

  • Director
18,500 2022-01-07 1

SCHMERTZLER MICHAEL

  • Director
133,766 2022-01-07 1

ZELDIS JEROME B

  • Director
18,500 2022-01-07 1

SVORONOS DAWN

  • Director
41,755 2022-01-07 2

JACOBSON ALLAN STEVEN

  • Director
20,348 2022-01-07 1

REEVE EMMA

  • Director
19,528 2022-01-07 1

OKEY STEPHANIE

  • Director
16,163 2022-01-07 2

SMITH MARY L.

  • Director
17,813 2022-01-07 3

SOUZA MARCIO CHIEF OPERATING OFFICER

  • Officer
6,744 2020-02-10 0

ROTHERA MARK CHIEF COMMERCIAL OFFICER

  • Officer
42,955 2017-05-24 0

KOVACS SHANE WILLIAM CHARLES CHIEF FINANCIAL OFFICER

  • Officer
37,850 2017-05-09 0

COMPLETE PHARMA HOLDINGS II, LLC

  • 10% Owner
No longer subject to file 2017-04-28 0

RENAUD RONALD C JR

  • Director
0 2017-01-03 0

KOPPEL ADAM

  • Director
0 2017-01-03 0

MCDONOUGH CAMERON GEOFFREY

  • Director
0 2017-01-03 0

ONG TUYEN CHIEF MEDICAL OFFICER

  • Officer
6,000 2017-01-03 0

SPIEGEL ROBERT J. CHIEF MEDICAL OFFICER

  • Officer
0 2016-01-04 0

ALDRICH RICHARD

  • Director
No longer subject to file 2015-06-08 0

KRANDA MICHAEL L

  • Director
2,242 2015-03-16 0

HIRAWAT CLAUDIA DE OLIVEIRA RIBEIRO PRESIDENT

  • Officer
No longer subject to file 2015-01-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PAUWELS ERIC CHIEF BUSINESS OFFICER

2022-04-21 16:02:48 -0400 2022-04-19 S 822 $42.52 d 49,772 direct 0.9809 -11.1419 0.9809 2 -11.1419 6

KLEIN MATTHEW B. CHIEF OPERATING OFFICER

2022-04-21 16:03:58 -0400 2022-04-19 S 897 $42.52 d 56,564 direct 0.9809 -11.1419 0.9809 2 -11.1419 6

PELTZ STUART WALTER CHIEF EXECUTIVE OFFICER by spouse

2022-04-15 16:04:01 -0400 2022-04-14 S 82 $45.28 d 38,646 indirect 1.6819 -6.2135 1.6819 2 -7.1245 5

BOULDING MARK ELLIOTT EXEC. VP AND CLO

2022-04-15 16:02:15 -0400 2022-04-13 M 2,276 $11.23 d 0 direct yes

BOULDING MARK ELLIOTT EXEC. VP AND CLO

2022-04-15 16:02:15 -0400 2022-04-13 S 2,276 $45.17 d 61,110 direct yes 1.6819 -6.2135 1.6819 2 -7.1245 5

BOULDING MARK ELLIOTT EXEC. VP AND CLO

2022-04-15 16:02:15 -0400 2022-04-13 M 2,276 $11.23 a 63,386 direct yes 1.6819 -6.2135 1.6819 2 -7.1245 5

BOULDING MARK ELLIOTT EXEC. VP AND CLO

2022-04-07 16:03:07 -0400 2022-04-05 M 5 $11.23 d 2,276 direct yes

BOULDING MARK ELLIOTT EXEC. VP AND CLO

2022-04-07 16:03:07 -0400 2022-04-05 S 5 $45.00 d 61,110 direct yes -0.28 -0.0933 5.5543 4 -0.28 2

BOULDING MARK ELLIOTT EXEC. VP AND CLO

2022-04-07 16:03:07 -0400 2022-04-05 M 5 $11.23 a 61,115 direct yes -0.28 -0.0933 5.5543 4 -0.28 2

HILL EMILY LUISA CHIEF FINANCIAL OFFICER

2022-04-01 16:20:06 -0400 2022-03-31 S 7,910 $37.78 d 29,259 direct yes 0.7619 -1.3392 1.3623 3 -1.3392 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PTC THERAPEUTICS INC PTCT 2022-05-16 16:45:03 UTC 0.5294 0.2906 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 16:15:03 UTC 0.5294 0.2906 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 15:45:03 UTC 0.5294 0.2906 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 15:15:03 UTC 0.5294 0.2906 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 14:45:03 UTC 0.57 0.25 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 14:15:03 UTC 0.57 0.25 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 13:45:04 UTC 0.57 0.25 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 13:15:03 UTC 0.57 0.25 850000
PTC THERAPEUTICS INC PTCT 2022-05-16 12:45:04 UTC 0.57 0.25 850000
PTC THERAPEUTICS INC PTCT 2022-05-13 22:15:03 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 21:45:03 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 21:15:03 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 20:45:03 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 20:15:03 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 19:45:04 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 19:15:03 UTC 0.57 0.25 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 18:45:03 UTC 0.5691 0.2509 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 18:15:03 UTC 0.5691 0.2509 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 17:45:03 UTC 0.5691 0.2509 750000
PTC THERAPEUTICS INC PTCT 2022-05-13 17:15:03 UTC 0.5691 0.2509 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund PTCT -491.0 shares, $-23582.73 2019-12-31 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund PTCT -19.0 shares, $-847.59 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund PTCT -143.0 shares, $-6685.25 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund PTCT -47.0 shares, $-2096.67 2020-03-31 N-PORT
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund PTCT -13499.0 shares, $-537665.17 2021-12-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund PTCT -593.0 shares, $-23619.19 2021-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund PTCT -3500.0 shares, $-139405.0 2021-12-31 N-PORT
AQR Funds- AQR Diversified Arbitrage Fund PTCT -20817.0 shares, $-829141.11 2021-12-31 N-PORT

Elevate your investments